New human evidence in women’s health and sports nutrition

Nexira, global leader in natural ingredients, will present its latest innovations at SupplySide Global. The program is built on one principle: benefits consumers can feel, substantiated by human data. Four areas will be in focus: women’s health, sports nutrition, fiber and longevity. BloomEase™ addresses PMS with a placebo-controlled study in 167 women, while a new clinical trial confirms in humans the vascular mechanism behind Vinitrox™ performance benefits.

Women’s health: BloomEase™ bridges an unmet need in PMS

Premenstrual syndrome remains one of the most common yet underserved needs in women’s health. Nexira will introduce BloomEase™, a new ingredient designed to support women before and during menstruation. It combines Achillea millefolium (yarrow) flower extract with marine-sourced magnesium to address both physical and mood-related symptoms.

In a placebo-controlled real-life study conducted in 167 women, BloomEase™ (520 mg once daily) demonstrated a significantly faster and greater reduction in menstrual discomfort vs placebo, along with improved quality of life and reduced PMS severity across cycles.

Sports nutrition: Vinitrox™. Push harder. Last longer. Recover faster

ViNitrox™ is a patented combination of apple and grape polyphenols designed to help recreational and competitive athletes get more from every workout, naturally and without stimulants. With new human clinical evidence, its performance story is now stronger than ever.

What do athletes really expect from a sports nutrition ingredient? To sustain performance. Delay fatigue. And support recovery.

That’s exactly where ViNitrox™ delivers. Extensive pre-clinical and clinical research has shown that ViNitrox™ can help sports consumers:

• Increase time to exhaustion by 9.7%
• Delay maximal perceived exertion by 12.8%
• Support recovery-related physiological processes

A new randomized, double-blind, placebo-controlled clinical study shows that ViNitrox™:

• Improves Flow-Mediated Dilation (FMD) by 41% vs placebo.
• Increases nitric oxide bioavailability and significantly reduces heart rate at rest and during exercise.
• Reduces inflammatory response by 48% following an acute challenge, supporting recovery-related physiological processes.

With a low 500 mg dose, a stimulant-free positioning and more than 10 years on the market, ViNitrox™ combines proven performance with a new generation of clinical science

Acacia fiber: 30 years of Fibregum™, still leading

2026 marks the 30th anniversary of Fibregum™, a milestone reflecting customer trust and more than 40 years of Nexira research on acacia fiber. Nexira will highlight its complete range, including Fibregum™ and inavea™, designed to support digestive comfort for GLP-1 users, enable fiber enrichment in nutrient-dense formulations and deliver prebiotic effects.

Thanks to its slow and progressive fermentation, acacia fiber offers a high digestive tolerance. At 10 g/day, it significantly increased Bifidobacterium and, in 120 subjects with IBS-C, significantly increased bowel movements by 1.3 per week.

Clinical study, n=20 (Cherbut et al., 2003)

Longevity: targeting cellular health and microbiome

Nexira is also entering the fast-growing longevity segment with a dedicated collection. Nu4Life™ is a new ingredient designed to support cellular regeneration and mitochondrial function, two key pillars of healthy aging. It is complemented by VinOgrape™ Plus, a grape polyphenol extract with demonstrated prebiotic activity, shown to modulate the gut microbiome and increase beneficial bacteria such as Akkermansia muciniphila, associated with metabolic health and age-related dysbiosis

Heading to SupplySide Global? Let’s connect!

Come meet the Nexira team and discover our latest innovations and scientific advances in health and wellness at Booth #6545!

Julie Impérato

Marketing & Communication Manager, Nexira

This communication is not intended to the final consumer. It provides scientific information for professionals only. Communication to final consumer has to be checked according to local regulation in force, since the conditions of use are beyond our control. This statement has not been evaluated by the FDA. These products are not intended to diagnose, treat, cure or prevent any disease.